Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 61,160,000 | 56,334,000 | 54,318,000 | 58,054,000 | 56,197,000 |
| Cost of Goods | 18,204,000 | 16,904,000 | 20,415,000 | 17,414,000 | 17,446,000 |
| Gross Profit | 42,956,000 | 39,430,000 | 33,903,000 | 40,640,000 | 38,751,000 |
| Operating Expenses | 22,865,000 | 27,536,000 | 21,146,000 | 22,523,000 | 20,827,000 |
| Operating Income | 20,091,000 | 11,894,000 | 12,757,000 | 18,117,000 | 17,924,000 |
| Interest Expense | 2,893,000 | 2,808,000 | 2,224,000 | 2,230,000 | 2,423,000 |
| Other Income | -10,601,000 | -5,370,000 | -4,283,000 | -2,410,000 | -2,512,000 |
| Pre-tax Income | 6,597,000 | 3,716,000 | 6,250,000 | 13,477,000 | 12,989,000 |
| Income Tax | 2,364,000 | -570,000 | 1,377,000 | 1,632,000 | 1,440,000 |
| Net Income Continuous | 4,233,000 | 4,286,000 | 4,873,000 | 11,845,000 | 11,549,000 |
| Minority Interests | -7,000 | -8,000 | -10,000 | -9,000 | -7,000 |
| Net Income | $4,226,000 | $4,278,000 | $4,863,000 | $11,836,000 | $11,542,000 |
| EPS Basic Total Ops | 0.25 | 0.25 | 0.29 | 0.70 | 0.69 |
| EPS Basic Continuous Ops | 0.25 | 0.25 | 0.29 | 0.70 | 0.69 |
| EPS Diluted Total Ops | 0.25 | 0.25 | 0.29 | 0.70 | 0.68 |
| EPS Diluted Continuous Ops | 0.25 | 0.25 | 0.29 | 0.70 | 0.68 |
| EBITDA(a) | $17,629,000 | $14,910,000 | $17,172,000 | $24,174,000 | $23,933,000 |